Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

NCT02871297 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02871297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02871297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Terminated
Start date
August 17, 2016
Completion date
April 19, 2022
Enrollment
662 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major